Clinical Trial Update: Bifidobacterium Infantis NLS Super Strain for Celiac Disease Patients on a Gluten-free Diet With Persistent Gastrointestinal Symptoms [Phase 2]

View source ↗

Summary

Phase 2 trial investigating Bifidobacterium infantis NLS super strain as an adjunct in celiac disease patients on a gluten-free diet with persistent GI symptoms…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• Bifidobacterium infantis NLS super strain (Bifidobacterium infantis NLS super strain)

Snippet

Sponsor: Global Institute of Probiotics | Conditions: Celiac Disease | Phase 2 | Status: COMPLETED